Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review

被引：47
|
作者：
Assi, Tarek [1 ]
Kattan, Joseph [1 ]
Rassy, Elie [1 ,2 ]
Nassereddine, Hussein [1 ]
Farhat, Fadi [1 ]
Honore, Charles [2 ]
Le Cesne, Axel [2 ]
Adam, Julien [2 ]
Mir, Olivier [2 ]
机构：
[1] St Joseph Univ, Dept Hematol Oncol, Fac Med, Beirut, Lebanon
[2] French Sarcoma Grp, Gustave Roussy Canc Campus, Villejuif, France
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2020年 / 153卷
关键词：
Liposarcoma; Soft tissue sarcoma; CDK4; MDM2; Palbociclib; Abemaciclib; Ribociclib; SOFT-TISSUE SARCOMA; PHASE-II; 1ST-LINE TREATMENT; SYNOVIAL SARCOMA; INHIBITOR; CANCER; DOXORUBICIN; ABEMACICLIB; PALBOCICLIB; EFFICACY;
D O I：
10.1016/j.critrevonc.2020.103029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Well-differentiated/dedifferentiated (WD/DD) liposarcomas, the most common form of liposarcomas, constitute up to 20 % of all soft tissue sarcomas. Several oncogenes are thought to be involved in liposarcoma pathogenesis, mainly MDM2, CDK4 and HMGA2. While MDM2 inhibitors are now tested in clinical trials, a second actionable and promising target appears to be cyclin-dependent kinase 4 (CDK4), which is amplified in up to 90 % of well differentiated or dedifferentiated (WD/DD) liposarcoma. With the paucity of available therapeutic options, the inhibition of CDK4 represent a potential therapeutic option. In this paper, we review the role of CDK4/6 inhibitors in targeting the commonly identified CDK4 amplification in WD/DD liposarcoma, with an emphasis on the published and currently ongoing trials.
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation
    Bockstaele, Laurence
    Bisteau, Xavier
    Paternot, Sabine
    Roger, Pierre P.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (15) : 4188 - 4200
  • [32] Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): Its relationship with cyclins and CDK "inhibitors"
    Bockstaele, Laurence
    Kooken, Hugues
    Libert, Frederick
    Paternot, Sabine
    Dumont, Jacques E.
    de Launoit, Yvan
    Roger, Pierre P.
    Coulonval, Katia
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (13) : 5070 - 5085
  • [33] The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification
    Shi, Chaoji
    Ju, Houyu
    Zhou, Rong
    Xu, Shengming
    Wu, Yunteng
    Gu, Ziyue
    Wang, Ying
    Chen, Wanling
    Huang, Xinyi
    Han, Yong
    Sun, Shuyang
    Li, Chuwen
    Wang, Min
    Zhou, Guoyu
    Zhang, Zhiyuan
    Li, Jiang
    Ren, Guoxin
    BMC MEDICINE, 2024, 22 (01):
  • [34] Calmodulin is essential for cyclin-dependent kinase 4 (Cdk4) activity and nuclear accumulation of cyclin D1-Cdk4 during G1
    Taulés, M
    Rius, E
    Talaya, D
    López-Girona, A
    Bachs, O
    Agell, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) : 33279 - 33286
  • [35] An analysis of available biomarker data for targeting cyclin-dependent kinases 4 and 6 (CDK4/6) in breast cancer
    Duso, Bruno Achutti
    Ferraro, Emanuela
    Mazzarella, Luca
    Jeremias, Camila Dagostim
    Curigliano, Giuseppe
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (03): : 129 - 138
  • [36] Expression and therapeutic implications of cyclin dependent kinase 4 (CDK4) in osteosarcoma
    Zhou, Yubing
    Hornicke, Francis
    Duan, Zhenfeng
    CANCER RESEARCH, 2017, 77
  • [37] Cyclin-dependent Kinase 4 (CDK4) is involved in the myelin sheath maintenance of hypothalamic neurons by modulating lipid biosynthesis
    Geller, S.
    GLIA, 2023, 71 : E731 - E731
  • [38] A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase
    Diehl, JA
    Sherr, CJ
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (12) : 7362 - 7374
  • [39] REGULATION OF CYCLIN D-DEPENDENT KINASE-4 (CDK4) BY CDK4-ACTIVATING KINASE
    KATO, JY
    MATSUOKA, M
    STROM, DK
    SHERR, CJ
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (04) : 2713 - 2721
  • [40] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    M Matsumoto
    M Furihata
    T Ishikawa
    Y Ohtsuki
    S Ogoshi
    British Journal of Cancer, 1999, 80 : 256 - 261
12345